Clinical Trials Directory

Trials / Completed

CompletedNCT01583855

Manual vs Amigo SmartTouch Atrial Fibrillation Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Leicester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation is a common form of heart rhythm disturbance that for some patients is treated by catheter ablation (making an ablation lesion or burn inside the heart using a fine wire (catheter)). A new system for manipulating the catheters has recently been introduced into clinical practice (the Amigo Remote Catheter System (RCS)). This trial is designed to answer two primary questions: a) is the contact force (the force with which the catheter comes into contact with the heart) any different using the RCS to manual techniques,and b)are the resulting ablation lesions within the heart any different in terms of the volume and contiguity of the lesions produced. Additionally the investigators aim to determine how the two techniques compare in success (the proportion of patients whose heart rhythm disturbance is corrected by the procedure).

Detailed description

The trial aims to recruit 50 patients, randomised into two groups, to have ablation for atrial fibrillation performed either using the RCS, or manually. Contact force information will be collected during the procedure, but the operators will be blinded to this information. Patients will have follow-up to include post-procedural cardiac magnetic resonance imaging and ambulatory electrocardiograms.

Conditions

Interventions

TypeNameDescription
PROCEDURECatheter ablation for atrial fibrillation, manualAblation for atrial fibrillation will be performed manually
DEVICEAblation using Amigo remote catheter systemAtrial fibrillation ablation will be performed using the Amigo remote catheter system

Timeline

Start date
2012-03-01
Primary completion
2015-02-28
Completion
2015-02-28
First posted
2012-04-24
Last updated
2020-01-30

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01583855. Inclusion in this directory is not an endorsement.